Health

Mediterranean Diet Cuts Heart Disease Risk by 28%, Major Study Finds

A 10-year longitudinal study of 120,000 adults found that close adherence to a Mediterranean diet reduced the risk of cardiovascular events by 28% compared with a Western diet.

April 25, 20261 min read 17 views
Share:

Decades of Evidence, Now Confirmed at Scale

A 10-year study tracking 120,000 adults across 14 countries found that those who closely followed a Mediterranean diet — rich in olive oil, vegetables, legumes, fish, and whole grains — had a 28% lower risk of heart attack, stroke, or cardiovascular death than those eating a typical Western diet.

Key Findings

  • Extra-virgin olive oil as the primary fat source was the strongest single predictor of cardiovascular protection.
  • Red meat consumption of more than twice per week doubled the risk of cardiovascular events.
  • Benefits were observed regardless of age, sex, or whether participants had pre-existing risk factors.

Practical Takeaways

Researchers emphasised that participants did not follow a strict diet but rather a broad pattern of eating. Even partial adoption — replacing processed snacks with nuts, or swapping butter for olive oil — produced measurable benefits within two years.

"The Mediterranean diet is not a fad. It is the most evidence-backed dietary pattern in the history of nutritional science," said the lead author of the study.

Related Stories

WHO Approves First Malaria Vaccine for Children in Sub-Saharan AfricaHealth

WHO Approves First Malaria Vaccine for Children in Sub-Saharan Africa

The World Health Organisation gave full approval to a new malaria vaccine showing 77% efficacy in children under five, calling it a "historic moment" in the fight against the disease.

Priya Sharma May 5, 2026
3 min read
FDA Approves New Alzheimer's Drug Showing Significant Cognitive Decline SlowdownHealth

FDA Approves New Alzheimer's Drug Showing Significant Cognitive Decline Slowdown

The FDA granted approval to lecanemab, a new Alzheimer's treatment that showed a 35% slowing of cognitive decline in early-stage patients in a landmark 18-month trial.

Priya Sharma May 1, 2026
3 min read

Comments (0)

Leave a Comment

Sign in or create an account to comment with your name saved.